DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Baird Maintains Outperform on Castle Biosciences, Raises Price Target to $38

Baird maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and raises the price target from $37 to $38.

Benzinga · 03/11/2020 13:30

Baird maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and raises the price target from $37 to $38.